Page last updated: 2024-08-18

4-butyrolactone and Cancer of Rectum

4-butyrolactone has been researched along with Cancer of Rectum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bach Knudsen, KE; Herzig, KH; Klintrup, K; Mäkelä, J; Mäkinen, MJ; Mutt, SJ; Nørskov, NP; Sirniö, P; Tuomisto, A; Väyrynen, JP1
Bach Knudsen, KE; Christensen, J; Egeberg, R; Johnsen, NF; Loft, S; Olsen, A; Overvad, K; Thomsen, BL; Tjønneland, A1

Other Studies

2 other study(ies) available for 4-butyrolactone and Cancer of Rectum

ArticleYear
Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
    Scientific reports, 2019, 08-01, Volume: 9, Issue:1

    Topics: 4-Butyrolactone; Aged; Case-Control Studies; Colon; Colonic Neoplasms; Diet, Western; Dietary Fiber; Feeding Behavior; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Intestinal Mucosa; Lignans; Male; Middle Aged; Rectal Neoplasms; Rectum; Risk Factors

2019
Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
    Cancer causes & control : CCC, 2010, Volume: 21, Issue:1

    Topics: 4-Butyrolactone; Case-Control Studies; Cohort Studies; Colonic Neoplasms; Denmark; Feeding Behavior; Female; Humans; Life Style; Lignans; Male; Middle Aged; Phytoestrogens; Rectal Neoplasms; Risk Factors

2010